All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The use of lipid nanoparticles (LNPs) technology in CAR-T therapy represents a significant advancement, offering improved delivery, reduced immunogenicity, and scalable manufacturing options. These advantages collectively enhance the efficacy, safety, and accessibility of CAR-T therapies, promising better outcomes for patients with various forms of cancer. At Creative Biolabs, we offer a comprehensive suite of IVT RNA and LNP manufacturing services designed to maximize the efficacy and safety of CAR-T therapy.
LNPs have emerged as a critical technology in the delivery of therapeutic agents, including nucleic acids such as RNA. At Creative Biolabs, we offer advanced LNP encapsulation services designed to optimize the delivery and functionality of IVT RNA in CAR-T cell therapy. Our services are meticulously designed to support the development and production of high-quality LNPs that are essential for the encapsulation and delivery of mRNA and other genetic cargo involved in CAR-T therapy. By leveraging our state-of-the-art technology and expertise, we ensure that the LNPs produced are highly efficient, stable, and capable of delivering their cargo with high specificity and minimal side effects. Our one-stop service covers every stage of LNP production, from initial design and formulation to scaling up for clinical and commercial use, ensuring that each product meets rigorous quality standards and regulatory requirements.
Fig.1 The advantages of CAR-LNP.1
LNPs have emerged as a critical technology in the delivery of therapeutic agents, including nucleic acids such as RNA. At Creative Biolabs, we offer advanced LNP encapsulation services designed to optimize the delivery and functionality of IVT RNA in CAR-T cell therapy. Our services are meticulously designed to support the development and production of high-quality LNPs that are essential for the encapsulation and delivery of mRNA and other genetic cargo involved in CAR-T therapy. By leveraging our state-of-the-art technology and expertise, we ensure that the LNPs produced are highly efficient, stable, and capable of delivering their cargo with high specificity and minimal side effects. Our one-stop service covers every stage of LNP production, from initial design and formulation to scaling up for clinical and commercial use, ensuring that each product meets rigorous quality standards and regulatory requirements.
We utilize state-of-the-art techniques and materials to create tailor-made solutions for LNP encapsulation, including:
Reference
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION